{"generic":"Monobenzone","drugs":["Benoquin","Monobenzone"],"mono":{"0":{"id":"380950-s-0","title":"Generic Names","mono":"Monobenzone"},"1":{"id":"380950-s-1","title":"Dosing and Indications","sub":{"0":{"id":"380950-s-1-4","title":"Adult Dosing","mono":"<b>Vitiligo:<\/b> apply 20% cream TOPICALLY to pigmented area 2 to 3 times daily for up to 4 months; once desired effect is achieved, may apply as needed (typically twice weekly) "},"1":{"id":"380950-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and effectiveness have not been established in children below the age of 12 years<\/li><li><b>Vitiligo:<\/b> (12 years of age and older) apply 20% cream TOPICALLY to pigmented area 2 to 3 times daily for up to 4 months; once desired effect is achieved, may apply as needed (typically twice weekly)<\/li><\/ul>"},"3":{"id":"380950-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Vitiligo<br\/>"}}},"3":{"id":"380950-s-3","title":"Contraindications\/Warnings","sub":[{"id":"380950-s-3-9","title":"Contraindications","mono":"<ul><li>conditions other than disseminated vitiligo<\/li><li>hypersensitivity to monobenzone<\/li><\/ul>"},{"id":"380950-s-3-10","title":"Precautions","mono":"<ul><li>do not use except for final depigmentation in extensive vitiligo<\/li><li>following therapy, the skin will be sensitive for the rest of the patient's life; sunscreens must be used during exposure to the sun<\/li><li>keep out of reach of children<\/li><\/ul>"},{"id":"380950-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"380950-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"380950-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Achromia of skin, Permanent, Burning sensation, Dermatitis, Skin irritation, Transient (mild)<br\/>"},"6":{"id":"380950-s-6","title":"Drug Name Info","sub":{"0":{"id":"380950-s-6-17","title":"US Trade Names","mono":"Benoquin<br\/>"},"2":{"id":"380950-s-6-19","title":"Class","mono":"Hypopigmentation Agent<br\/>"},"3":{"id":"380950-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"380950-s-7","title":"Mechanism Of Action","mono":"Monobenzone, a monobenzyl ether of hydroquinone, is a depigmenting agent which increases melanin excretion from the melanocytes.<br\/>"},"9":{"id":"380950-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>apply and rub a thin layer into pigmented area<\/li><li>avoid prolonged exposure to sunlight<\/li><\/ul>"},"10":{"id":"380950-s-10","title":"Monitoring","mono":"<ul><li>depigmentation<\/li><li>repigmentation<\/li><\/ul>"},"13":{"id":"380950-s-13","title":"Clinical Teaching","mono":"<ul><li>Following therapy, the skin will be sensitive for the rest of patient's life. Patient must use sunscreen whenever exposed to sunlight and employ proper precautions to protect skin from excessive UV exposure.<\/li><li>This drug may cause permanent achromia of skin or transient burning, dermatitis, or irritation of skin.<\/li><li>Advise patient to report non-transient irritation, burning, or dermatitis during drug therapy.<\/li><\/ul>"}}}